News

Document also urges health care to take leadership role in efforts to mitigate effects of weather-related events.

Scientists think they’ve hit on the mechanism by which certain patients are able to keep their levels of HIV low without relying on medication.

Bilirubin level, age, and sex should all be considered when assessing the need for a ciprofloxacin dose reduction in critically ill patients, German investigators reported in a new study published this week.

The rate of drug use-associated infective endocarditis hospitalizations and valve surgeries increased more than 12-fold in one US state, a new 10-year study shows.

A new report from the ECDC and WHO shows the disparity of new HIV diagnoses across Europe, with more than 80% of new cases occurring in Eastern Europe in 2017.

The results of a new Dutch study suggest a rationing protocol does not diminish the effectiveness of the vaccine.

Although decontamination strategies are thought to generally slash the rate of infection in ICUs, a new study finds that the use oral and digestive tract decontaminants in ventilated ICU patients is not associated with a reduction in antibiotic-resistant bloodstream infections.

Pharmacokinetic analyses provide evidence to support once-weekly dosing of rezafungin to prevent Aspergillus fumigatus in bone marrow transplant recipients.

A new study found that individuals who had low microbiota diversity prior to a bone marrow transplant were more likely to be at a higher risk for post-transplant complications.

As of September 2018, there were 139 new national drug shortages during this year alone, and a total of 238 overall, according to University of Utah (UA) Drug Information Service data.

Freeze-drying vaccines enables health officials to get vaccines to remote areas, but until now, it has not been possible for the fragile polio vaccine.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

The new test is approved to assist with detecting cytomegalovirus in newborns less than 21 days of age.

People living with HIV should get a flu shot each year, according to experts.

Little is known about the ecology and biology of the dangerous tick that the CDC has labeled an emerging disease threat to both humans and animals.

Are we investing in infection prevention programs like we should or are competing interests pulling resources?

As of October 31, 2018, the CDC has reported 457 clinical cases of confirmed C auris infection with a majority in New York (>50%), New Jersey, and Illinois.

Investigators have determined that norovirus outbreaks occur most frequently in health care settings and are often caused by strains of a virulent genotype.

This often-ignored zoonotic disease may be a rising problem around the world.

Through retrospective analysis, investigators have identified a second case of rat hepatitis E virus in a human, which has close genetic relation to the first case.

The FDA has announced that tahini imported from Israel is the likely source of a multistate outbreak of Salmonella Concord.

Draft guidance effectively outlines what infectious disease specialists have known for years—and leaves many unanswered questions.

A study in bat social dynamics provides a helpful reminder on infectious disease dynamics.

A new trial evaluating the efficacy of investigational therapeutics mAb114, remdesivir, and ZMapp has launched in the Democratic Republic of the Congo.

Secondary analyses indicate that bezlotoxumab is more effective in reducing C diff recurrence in patients with pre-specified risk factors.

A new study finds that despite CDC standards, stethoscopes aren't being disinfected.

Results from 2 new studies completed in the United States and Canada indicate that probiotic supplements do not produce any benefits for children with gastroenteritis.

A new study evaluated the use of red boxes in patient rooms to help encourage patient care while in isolation.

Why take 3 drugs when you can keep your viral load at bay with just 2? A new study confirms that the dolutegravir/lamivudine pairing is non-inferior to a 3-drug regimen and may offer fewer toxic side effects.